Core Points - The State Council has appointed Zheng Zhe as the Deputy Director of the National Health Commission, replacing Cao Xuetao, who has an academic background and previously served as the President of Nankai University [1][3] - Zheng Zhe is known for his expertise in cardiovascular surgery, focusing on clinical, research, and educational work related to heart diseases [1][2] Group 1 - Zheng Zhe's research group primarily focuses on the mechanisms and treatment methods for common cardiovascular diseases, including ischemic heart disease and arrhythmias, with several new devices for atrial fibrillation treatment being developed [2] - The team has established the "China Cardiovascular Surgery Registry Study (CCSR)" to enhance the quality of cardiovascular surgery across collaborating hospitals [2] - Zheng Zhe has led multiple national and provincial research projects, publishing results in prestigious journals and receiving several national science and technology awards [2] Group 2 - Zheng Zhe, born in 1971, is the first "post-70s" leader in the National Health Commission, while the outgoing Cao Xuetao, born in 1964, has a long-standing career in immunology and was elected as an academician of the Chinese Academy of Engineering in 2005 [3] - During Cao Xuetao's tenure as President of Nankai University, he implemented various initiatives to improve the university's academic performance and environment [3]
心血管专家郑哲履新国家卫健委副主任,此前是三甲医院书记
Nan Fang Du Shi Bao·2025-09-30 13:02